|
Aflibercept 2Mg/0.05Ml Inj,Oph Clinical Trials
1 actively recruiting trial
Also known as: Aflibercept 2-mg/0.05mL intravitreal ophthalmic injection
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.